Literature DB >> 4039165

[Metabolism of beclobrate in rat and man].

V W Roth, A Prox, U Ifflaender.   

Abstract

The major pathway of biotransformation of beclobrate [(2-[4-[(4-chlorophenyl)methyl]phenoxy]-2-methylbutyric acid ethyl ester] is the ester cleavage to beclobrinic acid (M1), which is eliminated as glucuronide. Subsequent metabolic attack is occurring via oxidation of the methylene bridge to the carbinol (M2) as well as to the benzophenone (M3). The p-chloro substituted phenyl ring is oxidated via a postulated arene oxide to the 2'- and 3'-phenol metabolites (M5 and M6) and to the trans-2',3'-dihydrodiol (M4). Except M4, all metabolites are eliminated exclusively as glucuronides.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039165

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  2 in total

Review 1.  Beclobrate:pharmacodynamic properties and therapeutic use in hyperlipidemia.

Authors:  C Wanner; H Wieland; P Schollmeyer; W H Hörl
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Effects of clofibric and beclobric acid in rat and monkey hepatocyte primary culture: influence on peroxisomal and mitochondrial beta-oxidation and the activity of catalase, glutathione S-transferase and glutathione peroxidase.

Authors:  W C Mennes; H M Wortelboer; G A Hassing; K van Sandwijk; A Timmerman; B P Schmid; U Jahn; B J Blaauboer
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.